Skip to main content
. 2023 Apr 7;10(16):2207768. doi: 10.1002/advs.202207768

Figure 6.

Figure 6

Fluorescent prodrug systems for glioblastoma. a) Schematic illustration of different targeted ligands for glioblastoma of cRGD peptide. Reproduced with permission.[ 128a ] Copyright 2013, American Chemical Society. b) Pep‐1 glioma‐homing‐peptide fabricated NPs targeting IL‐13Rα2. Reproduced with permission.[ 131 ] Copyright 2017, American Chemical Society. c) Schematic illustration of different targeted ligands for glioblastoma of NRP1. d) Representative sections of IL‐13Rα2 immunoreactivity in normal brain tissue (i) and different grades of glioma tissues (ii–v). Bar = 25 µm. Reproduced with permission.[ 129b ] Copyright 2017, American Chemical Society. e) Real‐time NIR‐imaging by SIRIS and surgical resection of GBM in a mouse model. Reproduced with permission.[ 123 ] Copyright 2019, Elsevier.